2018 Oncology Nursing Drug Handbook,Used

2018 Oncology Nursing Drug Handbook,Used

SKU: SONG1284143503 In Stock
Sale price$19.86 Regular price$28.37
Save $8.51
Quantity
Add to wishlist
Add to compare
Shipping & Tax will be calculated at Checkout.
Delivery time: 3-5 business days (USA)
Delivery time: 8-12 business days (International)
15 days return policy
Payment Options

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

Written especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs. New drugs include: avelumab (Bavencio), brigatinib (Alunbrig), durvalumab (Imfinzi), enasidenib (Idhifa), metronidazole hydrochloride (Flagyl), midostaurin (Rydapt), neratinib (Nerlynx), niraparib (Zejula), olaratumab (Lartruvo), ribociclib (Kisqali), rituximab and hyaluronidase human injection (Rituxan Hycela injection), rucaparib (Rubraca), telotristat ethyl (Xermelo), and tisagenlecleucel (Kymriah).

Shipping & Returns

Shipping
We ship your order within 2–3 business days for USA deliveries and 5–8 business days for international shipments. Once your package has been dispatched from our warehouse, you'll receive an email confirmation with a tracking number, allowing you to track the status of your delivery.

Returns
To facilitate a smooth return process, a Return Authorization (RA) Number is required for all returns. Returns without a valid RA number will be declined and may incur additional fees. You can request an RA number within 15 days of the original delivery date. For more details, please refer to our Return & Refund Policy page.

Shipping & Returns

Shipping
We ship your order within 2–3 business days for USA deliveries and 5–8 business days for international shipments. Once your package has been dispatched from our warehouse, you'll receive an email confirmation with a tracking number, allowing you to track the status of your delivery.

Returns
To facilitate a smooth return process, a Return Authorization (RA) Number is required for all returns. Returns without a valid RA number will be declined and may incur additional fees. You can request an RA number within 15 days of the original delivery date. For more details, please refer to our Return & Refund Policy page.

Warranty

We provide a 2-year limited warranty, from the date of purchase for all our products.

If you believe you have received a defective product, or are experiencing any problems with your product, please contact us.

This warranty strictly does not cover damages that arose from negligence, misuse, wear and tear, or not in accordance with product instructions (dropping the product, etc.).

Warranty

We provide a 2-year limited warranty, from the date of purchase for all our products.

If you believe you have received a defective product, or are experiencing any problems with your product, please contact us.

This warranty strictly does not cover damages that arose from negligence, misuse, wear and tear, or not in accordance with product instructions (dropping the product, etc.).

Secure Payment

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

We accept payments with :
Visa, MasterCard, American Express, Paypal, Shopify Payments, Shop Pay and more.

Secure Payment

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

We accept payments with :
Visa, MasterCard, American Express, Paypal, Shopify Payments, Shop Pay and more.

Related Products

You may also like

Frequently Asked Questions

  • Q: What is the main focus of the 2018 Oncology Nursing Drug Handbook? A: The handbook primarily focuses on drug therapy from the perspective of the nursing process, including nursing diagnoses, toxicities, and key points for assessment and intervention for patients with cancer.
  • Q: How often is the Oncology Nursing Drug Handbook updated? A: The Oncology Nursing Drug Handbook is updated annually to provide the most current information on drug therapies, side effects, and patient care.
  • Q: Who is the author of the 2018 Oncology Nursing Drug Handbook? A: The handbook is authored by Gail M. Wilkes, who brings expertise in oncology nursing.
  • Q: What new topics are covered in the latest edition of the handbook? A: The latest edition includes chapters on molecular and immunologic/biologic targeted therapies, simplifying the understanding of immune checkpoint inhibitors and recent advancements in immunotherapy.
  • Q: How many pages does the 2018 Oncology Nursing Drug Handbook contain? A: The handbook contains 1712 pages of comprehensive information on oncology nursing and drug therapies.
  • Q: What is the binding type of the handbook? A: The 2018 Oncology Nursing Drug Handbook is available in paperback binding, making it portable and easy to use.
  • Q: Is the 2018 Oncology Nursing Drug Handbook suitable for new nurses? A: Yes, the handbook is designed to assist both new and experienced nurses in understanding oncology drug therapies and patient management.
  • Q: What type of information can I expect to find in this handbook? A: You can find information on drug indications, side effects, nursing assessments, interventions, and updated therapies, including FDA-approved drugs.
  • Q: Are there any new drugs mentioned in the latest edition? A: Yes, the handbook includes new drugs such as avelumab, brigatinib, durvalumab, and others, along with their indications and side effects.
  • Q: When was the 2018 Oncology Nursing Drug Handbook published? A: The handbook was published on December 14, 2017.